1. Home
  2. LCUT vs NGEN Comparison

LCUT vs NGEN Comparison

Compare LCUT & NGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifetime Brands Inc.

LCUT

Lifetime Brands Inc.

HOLD

Current Price

$8.76

Market Cap

191.1M

ML Signal

HOLD

NGEN

NervGen Pharma Corp. Common stock

N/A

Current Price

$1.66

Market Cap

197.5M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
LCUT
NGEN
Founded
1945
2017
Country
United States
Canada
Employees
N/A
9
Industry
Industrial Machinery/Components
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
191.1M
197.5M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
LCUT
NGEN
Price
$8.76
$1.66
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$5.00
$18.00
AVG Volume (30 Days)
241.6K
833.4K
Earning Date
05-07-2026
04-02-2026
Dividend Yield
2.54%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$647,933,000.00
N/A
Revenue This Year
$3.74
N/A
Revenue Next Year
$1.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.90
$1.68
52 Week High
$9.80
$5.93

Technical Indicators

Market Signals
Indicator
LCUT
NGEN
Relative Strength Index (RSI) 54.62 31.86
Support Level $7.57 N/A
Resistance Level $9.61 $2.28
Average True Range (ATR) 0.67 0.14
MACD 0.01 0.00
Stochastic Oscillator 66.32 7.38

Price Performance

Historical Comparison
LCUT
NGEN

About LCUT Lifetime Brands Inc.

Lifetime Brands Inc is a U.S.-based company that designs, sources, and sells branded kitchenware, tableware, and other home solution products used in the home. The company's product portfolio comprises kitchen tools, cutlery, thermometers, cutting boards, spice racks, dinnerware, stemware, flatware, bath scales, thermal beverage ware, food storage, neoprene travel products, etc. These products are marketed under owned or licensed brands like Farberware, KitchenAid, Mikasa, Misto, Taylor, Sabatier, and Pfaltzgraff, among others. The company mainly sells its products directly to retailers and distributors, and a limited selection directly to consumers through its own websites. It has two reportable operating segments: U.S., which derives maximum revenue, and International.

About NGEN NervGen Pharma Corp. Common stock

NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.

Share on Social Networks: